London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Long-term results of corneal collagen cross-linking for progressive keratoconus

Poster Details

First Author: P.Fournié FRANCE

Co Author(s):    F. Malecaze              

Abstract Details



Purpose:

To evaluate the long-term results of corneal collagen crosslinking (CXL) in patients with progressive keratoconus.

Setting:

Purpan hospital, Department of Ophthalmology, Toulouse, France

Methods:

Retrospective consecutive, non-comparative, case series analysis of 350 eyes that have undergone CXL for progressive keratoconus. CXL was performed by instilling riboflavin 0.1% solution containing 20% dextran for 30 minutes before and during the 30 minutes of ultraviolet A irradiation (3 mW/cm2). Follow-up examinations were arranged at 3, 6, 12, 24, 36, 48, 60, and 72 months. Patients were tested for uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and maximum simulated keratometry value (Kmax).

Results:

Kmax flattened by -0.51±0.23 D, -0.72±0.21 D, -0.83±0.19 D, -0,78±0.24 D, -0,85±0.25 D, and -0,83±0.19 D at 12, 24, 36, 48, 60, and 72 months, respectively (all p <0.001). Both UCVA (-0.09±0.08 logMAR; p <0.05) and BSCVA (-0.07±0.06 logMAR; p <0.05) improved at 36 months.

Conclusions:

CXL is an efficient procedure to stabilize progressive keratoconus with initial Kmax decrease during the first 2 years. FINANCIAL INTEREST: NONE

Back to Poster listing